Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 1.8T | 2.4T | 1.9T | 2.1T |
Cost of revenue | 1.6T | 2.2T | 1.7T | 1.9T |
Gross profit | 193.1B | 287.4B | 209.9B | 167.5B |
Operating expense | ||||
Research & development | — | -116M | 17.4B | 15.4B |
Selling general and admin | 112.1B | 59.5B | 31.6B | 43.1B |
Other operating expenses | — | 24.6B | 16.0B | 9.5B |
Operating income | 193.1B | 132.1B | 85.5B | 36.5B |
Non operating interest income | ||||
Income | — | 23.4B | 25.7B | 28.1B |
Expense | — | 17.1B | 13.6B | 10.8B |
Other income expense | — | — | — | — |
Pretax income | 42.5B | 196.6B | 57.3B | 56.0B |
Tax provision | 12.3B | 79.3B | 12.0B | 15.3B |
Net income | 30.2B | 117.3B | 45.3B | 40.6B |
Basic EPS | 749.7 | — | 1.1K | 991 |
Diluted EPS | 749.7 | — | 1.1K | 991 |
Basic average shares | — | — | 42.9M | 41.0M |
Diluted average shares | — | — | 42.9M | 41.0M |
EBITDA | 193.1B | 289.1B | 104.9B | 103.8B |
Net income from continuing op. | — | 117.3B | 45.3B | 40.6B |
Minority interests | — | — | — | — |
Preferred stock dividends | — | — | — | — |